SOCKS DAVID A (President, CEO, Treas. & Sec.) sold 1.4% of their position (18K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $562.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/18/2021ACC: 0001209191-21-052287
DirectorOfficer· President, CEO, Treas. & Sec.
Since Oct 2019
-18K
Net shares
Net seller
$562.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−4.21K
Price / share
$30.47
Trade value
$128.25K
% of position
0.3%
8/16/2021
1.27M→1.26M
Common Stock
Indirect
Shares
−13.79K
Price / share
$31.49
Trade value
$434.29K
% of position
1.1%
8/16/2021
1.26M→1.25M
Total
Net shares
−18K
Net value
-$562.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/16/2021 | S · Sale | −4.21K | $30.47 | $128.25K | 0.3% | 1.27M | 1.26M |
| Common Stock Indirect | 8/16/2021 | S · Sale | −13.79K | $31.49 | $434.29K | 1.1% | 1.26M | 1.25M |
| Total | −18K | -$562.54K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned103.49
Total
103.49 indirect103.49
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 103.49 | Indirect |
| Total | 103.49 | 103.49 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported